TY - JOUR
T1 - Contractile properties are impaired in congenital myopathies
AU - Eisum, Anne-Sofie Vibæk
AU - Fornander, Freja
AU - Poulsen, Nanna Scharff
AU - Andersen, Annarita Ghosh
AU - Dahlqvist, Julia
AU - Andersen, Linda Kahr
AU - Witting, Nanna
AU - Vissing, John
N1 - Copyright © 2020 Elsevier B.V. All rights reserved.
PY - 2020/8
Y1 - 2020/8
N2 - The ratio between muscle strength and muscle cross-sectional area is called the specific force. Fatty replacement of muscles is seen in many myopathies, affecting the specific force, without necessarily affecting the ability of the remaining muscle fibers to contract. This ability is called the contractility and is the ratio between muscle strength and the lean muscle cross-sectional area, i.e. the contractile cross-sectional area. We hypothesized that contractility is disrupted in patients with congenital myopathy, because of defects in contractile proteins of the sarcomere. Peak torque across ankle and knee joints was measured by isokinetic dynamometry in 16 patients with congenital myopathy and 13 healthy controls. Five patients only participated partially in the dynamometer measurements due to severe muscle weakness. Dixon MRI technique was used to quantify muscle fat fractions and calculate cross-sectional area. Patients with congenital myopathy had lower cross-sectional area in all muscle groups (P<0.01), higher fat fraction (P<0.01) and less strength (P<0.005) in all studied muscle groups. Their fat content was more than doubled and peak torque lower than half that in healthy controls. Muscle contractility was reduced (P<0.01) in three of four patient muscle groups. In conclusion, muscle contractility was reduced in patients with congenital myopathy, across different diagnoses, and was independent of the level of muscle fat fraction, suggesting that intrinsic defects of the myocyte are responsible for reduced contractility.
AB - The ratio between muscle strength and muscle cross-sectional area is called the specific force. Fatty replacement of muscles is seen in many myopathies, affecting the specific force, without necessarily affecting the ability of the remaining muscle fibers to contract. This ability is called the contractility and is the ratio between muscle strength and the lean muscle cross-sectional area, i.e. the contractile cross-sectional area. We hypothesized that contractility is disrupted in patients with congenital myopathy, because of defects in contractile proteins of the sarcomere. Peak torque across ankle and knee joints was measured by isokinetic dynamometry in 16 patients with congenital myopathy and 13 healthy controls. Five patients only participated partially in the dynamometer measurements due to severe muscle weakness. Dixon MRI technique was used to quantify muscle fat fractions and calculate cross-sectional area. Patients with congenital myopathy had lower cross-sectional area in all muscle groups (P<0.01), higher fat fraction (P<0.01) and less strength (P<0.005) in all studied muscle groups. Their fat content was more than doubled and peak torque lower than half that in healthy controls. Muscle contractility was reduced (P<0.01) in three of four patient muscle groups. In conclusion, muscle contractility was reduced in patients with congenital myopathy, across different diagnoses, and was independent of the level of muscle fat fraction, suggesting that intrinsic defects of the myocyte are responsible for reduced contractility.
KW - Congenital myopathy
KW - Contractile cross-sectional area
KW - Dixon technique
KW - Muscle contractility
UR - http://www.scopus.com/inward/record.url?scp=85087985825&partnerID=8YFLogxK
U2 - 10.1016/j.nmd.2020.06.007
DO - 10.1016/j.nmd.2020.06.007
M3 - Journal article
C2 - 32675003
SN - 0960-8966
VL - 30
SP - 649
EP - 655
JO - Neuromuscular disorders : NMD
JF - Neuromuscular disorders : NMD
IS - 8
ER -